Ideation: 2BSPCP CSI's molecular dynamics simulations and modeling capabilities, including but not limited to, large molecule aggregration, and Merck's interest therein as it relates to potential capabilities to ongoing research and development programs.

For more information or to license this innovation:

IDEA #2BSPCP CSI's molecular dynamics simulations and modeling capabilities, including but not limited to, large molecule aggregration, and Merck's interest therein as it relates to potential capabilities to ongoing research and development programs.